Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform.
Meliora Therapeutics has raised $11.0M in total funding. The most recent round was Seed. The last funding was announced in September 2022.
Meliora Therapeutics's investors include HOF Capital, Village Global, Obvious Ventures, Pebblebed, ZhenFund.
Meliora Therapeutics is headquartered in San Francisco, United States.
Meliora Therapeutics is a biotech startup that is developing a machine learning-driven platform.
Meliora Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Meliora Therapeutics — Funding & Investors." VCBacked, September 29, 2022, https://www.vcbacked.co/company/meliora-therapeutics. Accessed September 5, 2026.
VCBacked. (2022). Meliora Therapeutics — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/meliora-therapeutics
{{cite web |title=Meliora Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/meliora-therapeutics |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated